文献速递药物相互作用特殊人群用药

离体人肝常温机械灌注模型评估肝脏提取、胆汁排泄及转运体功能

Novel Explanted Human Liver Model to Assess Hepatic Extraction, Biliary Excretion and Transporter Function.
PubMed 文献 · Clin Pharmacol Ther · 2023-05-11

研究建立离体病变人肝常温机械灌注(NMP)模型,纳入11例肝脏(7例肝硬化、4例非肝硬化),灌注120分钟给予瑞舒伐他汀、地高辛、二甲双胍和呋塞米混合探针,再120分钟后联合 perpetrator 药物研究药物相互作用。结果显示肝脏在360分钟NMP中保持活力和功能,肝提取率接近体内报道值,肝硬化使瑞舒伐他汀和地高辛的Cmax分别增加11.50倍和2.89倍。

要点

  • 离体病变人肝NMP模型可评估肝提取、清除、胆汁排泄及DDI。
  • 肝硬化使瑞舒伐他汀和地高辛Cmax分别增加11.50倍和2.89倍。
  • 二甲双胍和呋塞米在肝硬化与非肝硬化间无主要差异。

核心结论

  • 离体病变人肝NMP是评估肝提取、清除、胆汁排泄和DDI的优良模型。

研究设计与样本

  • 研究纳入11例离体病变人肝,其中7例肝硬化、4例非肝硬化,行常温机械灌注(NMP)。

主要发现

  • 肝脏在360分钟NMP期间显示良好活力和功能,肝提取率接近体内报道值。
  • 肝硬化使瑞舒伐他汀和地高辛的Cmax分别增加11.50倍和2.89倍(与非肝硬化肝相比)。
  • 二甲双胍和呋塞米在肝硬化与非肝硬化肝间未观察到主要差异。
  • 瑞舒伐他汀或地高辛与perpetrator药物的相互作用在非肝硬化肝中比肝硬化肝更明显。

临床怎么用

  • 该模型可用于研究病变肝脏中OATP1B1/1B3、P-gp、BCRP和OCT1底物的药代动力学特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Realistic models predicting hepatobiliary processes in health and disease are lacking. We therefore aimed to develop a physiologically relevant human liver model consisting of normothermic machine perfusion (NMP) of explanted diseased human livers that can assess hepatic extraction, clearance, biliary excretion, and drug-drug interaction (DDI). Eleven livers were included in the study, seven with a cirrhotic and four with a noncirrhotic disease background. After explantation of the diseased liver, NMP was initiated. After 120 minutes of perfusion, a drug cocktail (rosuvastatin, digoxin, metformin, and furosemide; OATP1B1/1B3, P-gp, BCRP, and OCT1 model compounds) was administered to the portal vein and 120 minutes later, a second bolus of the drug cocktail was co-administered with perpetrator drugs to study relevant DDIs. The explanted livers showed good viability and functionality during 360 minutes of NMP. Hepatic extraction ratios close to in vivo reported values were measured. Hepatic clearance of rosuvastatin and digoxin showed to be the most affected by cirrhosis with an increase in maximum plasma concentration (Cmax ) of 11.50 and 2.89 times, respectively, compared with noncirrhotic livers. No major differences were observed for metformin and furosemide. Interaction of rosuvastatin or digoxin with perpetrator drugs were more pronounced in noncirrhotic livers compared with cirrhotic livers. Our results demonstrated that NMP of human diseased explanted livers is an excellent model to assess hepatic extraction, clearance, biliary excretion, and DDI. Gaining insight into pharmacokinetic profiles of OATP1B1/1B3, P-gp, BCRP, and OCT1 model compounds is a first step toward studying transporter functions in diseased livers.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Stevens LJ, Dubbeld J, Doppenberg JB, et al. Novel Explanted Human Liver Model to Assess Hepatic Extraction, Biliary Excretion and Transporter Function. Clin Pharmacol Ther. 2023. PMID: 37042227. doi:10.1002/cpt.2905

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。